The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Wednesday:** Valeant Pharmaceuticals International Inc and its partner William Ackman plan to boost their offer by about $15 per share, valuing Allergan Inc at more than $190 per share, according to a person familiar with the matter.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 1.68% or $3.12/share to $189.32. In the past year, the shares have traded as low as $88.34 and as high as $189.41. On average, 2065290 shares of AGN exchange hands on a given day and today's volume is recorded at 1021204.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 0.15% or $0.19/share to $125.42. In the past year, the shares have traded as low as $102.60 and as high as $153.10. On average, 2675780 shares of VRX exchange hands on a given day and today's volume is recorded at 335958.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 0.43% or $0.6/share to $140.44. In the past year, the shares have traded as low as $107.30 and as high as $170.45. On average, 450594 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 48576.
Source
